GlassScriptPhysician profile
Roger W Archer
NPI 1508877846
$1,682.59
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $688 · 2020: $830 · 2021: $165.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $346.83 | 2019-2020 | |
| Novo Nordisk INC | $287.46 | 2019-2021 | |
| Amgen INC. | $182.95 | 2019-2021 | |
| Amarin Pharma, INC. | $160.67 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $128.86 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.35 | 2020-2021 | |
| Glaxosmithkline, LLC. | $95.13 | 2019-2021 | |
| Astellas Pharma US INC | $93.75 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $56.62 | 2020 | |
| Lilly USA, LLC | $41.93 | 2019-2021 | |
| Pfizer INC. | $40.67 | 2019-2020 | |
| Allergan, INC. | $32.07 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $26.64 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $16.22 | 2020 | |
| Abbott Laboratories | $12.31 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $11.88 | 2020 | |
| Merck Sharp & Dohme LLC | $11.82 | 2020 | |
| Dexcom, INC. | $11.43 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roger Archer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.